Balance Sheet Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 10:05:28 13/03/2026 pm IST			5-day change	1st Jan Change
71.00 ^GBX	-1.39%		+5.19%	+22.41%

24/02	Avacta hails new data supporting proprietary preCision platform	AN
24/02	Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis	MT

da39253ebc974a12.z9LzberPbsQdHaNRBqfK8Wv-Y3IXJ-_sy6sWf3EK5a8.9oGiVYeiV7JEafM1U-PziTyqEQN6TIadje9uRhs9h8SmgqALoqEWmytQ6g

Published financial data: AVACTA GROUP PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	36.36L	29.41L	96.53L	2.32Cr	1L
Total Revenues	36.36L	29.41L	96.53L	2.32Cr	1L
Cost of Goods Sold, Total	24.62L	38.88L	34.6L	1.2Cr	-
Gross Profit	11.74L	-9L	61.93L	1.12Cr	1L
Selling General & Admin Expenses, Total	73.15L	81.36L	1.12Cr	1.69Cr	1.2Cr
Stock-Based Compensation (IS)	31.08L	50.58L	74.9L	29.06L	41.07L
R&D Expenses	89.61L	1.35Cr	1.11Cr	1.45Cr	1.43Cr
Depreciation & Amortization - (IS)	11.25L	14.62L	19.04L	26.38L	14.89L
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	10.33L	16T
Other Operating Expenses, Total	2.05Cr	2.81Cr	3.17Cr	3.8Cr	3.19Cr
Operating Income	-1.93Cr	-2.91Cr	-2.55Cr	-2.67Cr	-3.18Cr
Interest Expense, Total	-93T	-1L	-27.01L	-1.53Cr	-98.54L
Interest And Investment Income	43T	17T	91T	7L	7L
Net Interest Expenses	-50T	-1L	-26.1L	-1.46Cr	-91.91L
Income (Loss) On Equity Invest.	-2L	-	-11.52L	-8L	-7L
Other Non Operating Income (Expenses)	-	-	-41L	1.57Cr	1.28Cr
EBT, Excl. Unusual Items	-1.96Cr	-2.92Cr	-3.34Cr	-2.65Cr	-2.9Cr
Merger & Related Restructuring Charges	-	-	-30.22L	-3L	-
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-17.41L	-	-52.25L	-5L	-
EBT, Incl. Unusual Items	-2.13Cr	-2.92Cr	-4.16Cr	-2.73Cr	-2.9Cr
Income Tax Expense	-24.52L	-28.2L	-21.02L	-23.7L	4L
Earnings From Continuing Operations	-1.89Cr	-2.64Cr	-3.95Cr	-2.49Cr	-2.94Cr
Earnings Of Discontinued Operations	-	58T	4L	-	-2.34Cr
Net Income to Company	-1.89Cr	-2.63Cr	-3.92Cr	-2.49Cr	-5.28Cr
Net Income - (IS)	-1.89Cr	-2.63Cr	-3.92Cr	-2.49Cr	-5.28Cr
Net Income to Common Incl Extra Items	-1.89Cr	-2.63Cr	-3.92Cr	-2.49Cr	-5.28Cr
Net Income to Common Excl. Extra Items	-1.89Cr	-2.64Cr	-3.95Cr	-2.49Cr	-2.94Cr
Per Share Items
Net EPS - Basic	-0.08	-0.11	-0.15	-0.09	-0.15
Basic EPS - Continuing Operations	-0.08	-0.11	-0.15	-0.09	-0.09
Basic Weighted Average Shares Outstanding	23Cr	25Cr	26Cr	27Cr	34Cr
Net EPS - Diluted	-0.08	-0.11	-0.15	-0.09	-0.15
Diluted EPS - Continuing Operations	-0.08	-0.11	-0.15	-0.09	-0.09
Diluted Weighted Average Shares Outstanding	23Cr	25Cr	26Cr	27Cr	34Cr
Normalized Basic EPS	-0.05	-0.07	-0.08	-0.06	-0.05
Normalized Diluted EPS	-0.05	-0.07	-0.08	-0.06	-0.05
Supplemental Items
EBITDA	-1.84Cr	-2.76Cr	-2.43Cr	-2.46Cr	-3.04Cr
EBITA	-1.93Cr	-2.91Cr	-2.54Cr	-2.57Cr	-3.18Cr
EBIT	-1.93Cr	-2.91Cr	-2.55Cr	-2.67Cr	-3.18Cr
EBITDAR	-1.84Cr	-2.76Cr	-2.43Cr	-2.44Cr	-3.02Cr
Effective Tax Rate - (Ratio)	11.49	9.66	5.05	8.68	-1.53
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-24.52L	-28.2L	-20.39L	-20.91L	-18.23L
Total Deferred Taxes	-	-	-63T	-3L	22.67L
Normalized Net Income	-1.23Cr	-1.82Cr	-2.09Cr	-1.66Cr	-1.81Cr
Interest on Long-Term Debt	93T	1L	28.34L	1.53Cr	1.02Cr
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	99.68L	1.43Cr	1.71Cr	1.46Cr	1.43Cr
Net Rental Expense, Total	2T	29T	42T	2L	2L
Imputed Operating Lease Interest Expense	1.04T	15.86T	28.08T	5L	3L
Imputed Operating Lease Depreciation	961	13.14T	13.92T	-3L	-2L
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	31.08L	50.58L	74.9L	29.06L	41.07L
Total Stock-Based Compensation	31.08L	50.58L	74.9L	29.06L	41.07L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.79Cr	2.62Cr	4.18Cr	1.66Cr	1.29Cr
Short Term Investments	2Cr	-	-	-	-
Total Cash And Short Term Investments	4.79Cr	2.62Cr	4.18Cr	1.66Cr	1.29Cr
Accounts Receivable, Total	15.73L	12.97L	24.7L	32.67L	-
Other Receivables	24.83L	33.12L	78.59L	38.56L	33.75L
Total Receivables	40.56L	46.09L	1.03Cr	71.23L	33.75L
Inventory	2L	2L	16.81L	25.85L	-
Prepaid Expenses	10.39L	24.68L	17.6L	17.01L	10.32L
Other Current Assets, Total	-	12.79L	-	-	2.29Cr
Total Current Assets	5.33Cr	3.47Cr	5.56Cr	2.8Cr	4.02Cr
Gross Property Plant And Equipment	98L	1.02Cr	1.33Cr	1.59Cr	65.12L
Accumulated Depreciation	-50.09L	-58.3L	-54.71L	-59.4L	-37.27L
Net Property Plant And Equipment	47.91L	43.41L	77.98L	99.86L	27.85L
Long-term Investments	-	-	29.76L	40.79L	34.45L
Goodwill	23.15L	15.39L	1.42Cr	1.7Cr	15.39L
Other Intangibles, Total	2L	3L	1.21Cr	1.31Cr	3L
Deferred Tax Assets Long-Term	-	-	-	3L	-
Deferred Charges Long-Term	68.68L	60.46L	0	7L	0
Total Assets	6.75Cr	4.7Cr	9.26Cr	7.32Cr	4.83Cr
Liabilities
Accounts Payable, Total	9L	6L	24.87L	37.3L	27.96L
Accrued Expenses, Total	18.19L	28.36L	37.67L	40.26L	29.06L
Short-term Borrowings	-	-	1.87Cr	1.61Cr	2.05Cr
Current Portion of Long-Term Debt	-	-	3.91Cr	1.85Cr	12.81L
Current Portion of Leases	3L	3L	13.61L	12.95L	10L
Current Income Taxes Payable	2L	2L	9L	10.49L	1L
Unearned Revenue Current, Total	6L	51T	11.41L	3L	-
Other Current Liabilities	5T	4L	2L	1L	87.27L
Total Current Liabilities	37.81L	43.68L	6.76Cr	4.51Cr	3.73Cr
Long-Term Debt	-	-	-	2L	-
Long-Term Leases	17.52L	14.12L	37.53L	57.35L	14.82L
Deferred Tax Liability Non Current	-	-	28.45L	3L	-
Other Non Current Liabilities	-	-	-	-	2L
Total Liabilities	55.33L	57.8L	7.42Cr	5.14Cr	3.9Cr
Common Stock, Total	2.53Cr	2.54Cr	2.66Cr	2.84Cr	3.69Cr
Additional Paid In Capital	5.41Cr	5.45Cr	6.22Cr	8.32Cr	12Cr
Retained Earnings	-1.29Cr	-3.41Cr	-6.6Cr	-8.58Cr	-14Cr
Treasury Stock	-29.61L	-29.62L	-27.55L	-24.85L	-23.73L
Comprehensive Income and Other	-16.52L	-16.48L	-16.02L	-16.01L	-20.43L
Total Common Equity	6.19Cr	4.12Cr	1.84Cr	2.18Cr	92.81L
Total Equity	6.19Cr	4.12Cr	1.84Cr	2.18Cr	92.81L
Total Liabilities And Equity	6.75Cr	4.7Cr	9.26Cr	7.32Cr	4.83Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	25Cr	25Cr	27Cr	36Cr	39Cr
ECS Total Common Shares Outstanding	25Cr	25Cr	26Cr	28Cr	37Cr
Book Value / Share	0.25	0.17	0.07	0.08	0.03
Tangible Book Value	5.94Cr	3.93Cr	-78.86L	-83.2L	74.37L
Tangible Book Value Per Share	0.24	0.16	-0.03	-0.03	0.02
Total Debt	20.42L	17.03L	6.29Cr	4.18Cr	2.42Cr
Net Debt	-4.59Cr	-2.45Cr	2.12Cr	2.52Cr	1.13Cr
Debt Equivalent Oper. Leases	16T	2L	3L	17.76L	12.56L
Equity Method Investments, Total	-	-	29.76L	40.79L	34.45L
Account Code - Inventory Valuation	5	5	5	5	6
Inventories - Raw Materials, Total	2L	2L	2L	9L	-
Inventories - Work In Process, Total	-	-	-	4L	-
Inventories - Finished Goods, Total	41T	-	14.83L	13.15L	-
Machinery, Total	54.91L	58.65L	64.57L	72.25L	31.28L
Full Time Employees	123	133	120	154	151

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-1.89Cr	-2.63Cr	-3.92Cr	-2.49Cr	-5.28Cr
Depreciation & Amortization - CF	11.25L	14.61L	19.5L	26.38L	14.28L
Amortization of Goodwill and Intangible Assets - (CF)	4T	8T	2L	10L	16T
Depreciation & Amortization, Total	11.29L	14.69L	21.22L	36.09L	14.44L
Amortization of Deferred Charges, Total - (CF)	10.25L	9L	9L	62T	-
(Gain) Loss From Sale Of Asset	6T	30T	52T	-2T	9T
Asset Writedown & Restructuring Costs	17.41L	-	52.25L	5L	-
(Income) Loss On Equity Investments - (CF)	2L	-	11.52L	8L	7L
Stock-Based Compensation (CF)	31.08L	50.83L	74.9L	29.06L	41.07L
Net Cash From Discontinued Operations	-	50T	-3L	-	13.39L
Other Operating Activities, Total	3L	-5L	22.61L	13.77L	2.13Cr
Change In Accounts Receivable	-8L	-15.99L	22.25L	8L	-2L
Change In Inventories	-91T	13T	52T	2L	-
Change In Accounts Payable	16.27L	5L	15.96L	-3L	6L
Change in Unearned Revenues	-	-	-	28T	-
Cash from Operations	-1.06Cr	-2.05Cr	-1.64Cr	-1.49Cr	-2.36Cr
Capital Expenditure	-12.79L	-11.62L	-6L	-11.24L	-3L
Sale of Property, Plant, and Equipment	-	-	50T	60T	-
Cash Acquisitions	-	-	-2.49Cr	-77.99L	-
Sale (Purchase) of Intangible assets	-4L	-2L	-36T	-96T	-16T
Investment in Marketable and Equity Securities, Total	-2.02Cr	2Cr	-	-	-
Other Investing Activities, Total	-	-	4L	-42T	-10.92L
Cash from Investing	-2.19Cr	1.87Cr	-2.5Cr	-90.01L	-14.31L
Long-Term Debt Issued, Total	-	-	5.22Cr	-	-
Total Debt Issued	-	-	5.22Cr	-	-
Short Term Debt Repaid, Total	-	-	-	-	-25.5L
Long-Term Debt Repaid, Total	-3L	-3L	-8L	-16.96L	-9L
Total Debt Repaid	-3L	-3L	-8L	-16.96L	-34.63L
Issuance of Common Stock	5.49Cr	5L	94.86L	4L	3.19Cr
Other Financing Activities, Total	-29.6L	-	-40.32L	-	-23.18L
Cash from Financing	5.16Cr	2L	5.69Cr	-12.98L	2.61Cr
Foreign Exchange Rate Adjustments	-	4T	2L	17T	84T
Miscellaneous Cash Flow Adjustments	-	-1L	-	-	-
Net Change in Cash	1.91Cr	-17.03L	1.56Cr	-2.52Cr	11.51L
Supplemental Items
Cash Interest Paid	93T	1L	2L	3L	1L
Cash Income Tax Paid (Refund)	-	-	2L	-66.33L	-11.7L
Levered Free Cash Flow	-74.38L	-1.48Cr	-86.28L	-1.77Cr	-3.14Cr
Unlevered Free Cash Flow	-73.79L	-1.47Cr	-69.4L	-81.78L	-2.52Cr
Change In Net Working Capital	-11.08L	26.16L	9L	-31.63L	1.06Cr
Net Debt Issued / Repaid	-3L	-3L	5.14Cr	-16.96L	-34.63L

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-25.21	-31.76	-22.85	-20.1	-32.74
Return on Total Capital	-26.68	-34.01	-25.68	-22.63	-40.93
Return On Equity %	-43.06	-51.14	-132.55	-116.57	-224.77
Return on Common Equity	-43.06	-51.14	-132.55	-116.57	-224.77
Margin Analysis
Gross Profit Margin %	32.29	-32.2	64.16	48.37	100
SG&A Margin	201.18	276.64	116.36	72.5	10.66T
EBITDA Margin %	-507.43	-938.93	-252.18	-105.89	-26.87T
EBITA Margin %	-531.66	-988.61	-262.73	-110.75	-28.14T
EBIT Margin %	-531.77	-988.88	-264.51	-114.93	-28.15T
Income From Continuing Operations Margin %	-519.55	-896.77	-409.61	-107.31	-26.04T
Net Income Margin %	-519.55	-894.8	-405.98	-107.31	-46.76T
Net Avail. For Common Margin %	-519.55	-896.77	-409.61	-107.31	-26.04T
Normalized Net Income Margin	-336.94	-620.41	-216.22	-71.31	-16.03T
Levered Free Cash Flow Margin	-204.55	-503.33	-89.38	-76.31	-27.79T
Unlevered Free Cash Flow Margin	-202.95	-500.61	-71.9	-35.18	-22.34T
Asset Turnover
Asset Turnover	0.08	0.05	0.14	0.28	0
Fixed Assets Turnover	0.92	0.64	1.59	2.61	0.02
Receivables Turnover (Average Receivables)	3.21	2.05	5.13	8.1	-
Inventory Turnover (Average Inventory)	12.19	17.79	3.7	5.63	-
Short Term Liquidity
Current Ratio	14.08	7.95	0.82	0.62	1.08
Quick Ratio	13.74	7.05	0.77	0.53	0.44
Operating Cash Flow to Current Liabilities	-2.81	-4.69	-0.24	-0.33	-0.63
Days Sales Outstanding (Average Receivables)	113.9	178.09	71.22	45.04	-
Days Outstanding Inventory (Average Inventory)	30.03	20.51	98.63	64.86	-
Average Days Payable Outstanding	111.35	67.54	112.33	87.91	-
Cash Conversion Cycle (Average Days)	32.58	131.07	57.52	21.99	-
Long Term Solvency
Total Debt/Equity	3.3	4.13	341.38	191.87	260.92
Total Debt / Total Capital	3.19	3.97	77.34	65.74	72.29
LT Debt/Equity	2.83	3.43	20.35	27.31	15.97
Long-Term Debt / Total Capital	2.74	3.29	4.61	9.36	4.42
Total Liabilities / Total Assets	8.2	12.3	80.1	70.21	80.77
EBIT / Interest Expense	-207.9	-227.21	-9.45	-1.75	-3.23
EBITDA / Interest Expense	-195.76	-215.73	-8.67	-1.51	-3.08
(EBITDA - Capex) / Interest Expense	-209.52	-224.81	-8.87	-1.58	-3.11
Total Debt / EBITDA	-0.11	-0.06	-2.69	-1.81	-0.8
Net Debt / EBITDA	2.52	0.89	-0.9	-1.09	-0.37
Total Debt / (EBITDA - Capex)	-0.1	-0.06	-2.63	-1.73	-0.79
Net Debt / (EBITDA - Capex)	2.35	0.85	-0.88	-1.04	-0.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.53	37.17	228.22	140.83	-96.04
Gross Profit, 1 Yr. Growth %	-11.01	-364.53	-753.96	55.24	-96.02
EBITDA, 1 Yr. Growth %	57.51	57.51	-12.84	1.13	46.53
EBITA, 1 Yr. Growth %	52.63	56.36	-12.77	1.52	44.5
EBIT, 1 Yr. Growth %	51.93	56.37	-12.21	4.64	44.58
Earnings From Cont. Operations, 1 Yr. Growth %	71.39	60.85	49.92	-32.54	0.95
Net Income, 1 Yr. Growth %	71.39	39.3	48.92	-31.9	58.89
Normalized Net Income, 1 Yr. Growth %	53.81	54.78	14.39	-20.58	-6.03
Diluted EPS Before Extra, 1 Yr. Growth %	-8.57	45.44	46.46	-36.83	-20.11
Accounts Receivable, 1 Yr. Growth %	127.97	-17.55	90.44	32.27	-
Inventory, 1 Yr. Growth %	58.97	-23.79	789.42	53.78	-
Net Property, Plant and Equip., 1 Yr. Growth %	55.35	-9.39	79.64	28.06	-72.11
Total Assets, 1 Yr. Growth %	137.46	-30.33	97.12	-21.23	-34.05
Tangible Book Value, 1 Yr. Growth %	170.63	-33.74	-120.04	56.13	-156.25
Common Equity, 1 Yr. Growth %	139.95	-33.44	-55.27	3.86	-45.09
Cash From Operations, 1 Yr. Growth %	15.84	92.69	-19.87	-9.49	58.67
Capital Expenditures, 1 Yr. Growth %	193.19	-9.15	-51.98	101.43	57.56
Levered Free Cash Flow, 1 Yr. Growth %	-	109.23	-41.61	105.6	96.06
Unlevered Free Cash Flow, 1 Yr. Growth %	-	109.75	-52.78	17.84	262.29
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-13.05	112.19	181.15	-89.18
Gross Profit, 2 Yr. CAGR %	-	-15.28	315.92	244.58	-87.51
EBITDA, 2 Yr. CAGR %	-	53.54	17.83	-6.12	11.69
EBITA, 2 Yr. CAGR %	-	51.52	16.78	-5.9	11.97
EBIT, 2 Yr. CAGR %	-	51.17	17.17	-4.15	11.62
Earnings From Cont. Operations, 2 Yr. CAGR %	-	54.69	55.29	-2.74	-10.8
Net Income, 2 Yr. CAGR %	-	54.52	44.03	-2.64	20.1
Normalized Net Income, 2 Yr. CAGR %	-	51.35	33.06	-4.68	-6.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-	7.43	45.95	-6.97	-23.21
Accounts Receivable, 2 Yr. CAGR %	-	37.1	25.31	58.71	-
Inventory, 2 Yr. CAGR %	-	10.07	160.35	269.83	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	18.64	27.58	51.67	-40.24
Total Assets, 2 Yr. CAGR %	-	28.62	17.19	24.79	-27.93
Tangible Book Value, 2 Yr. CAGR %	-	33.91	-63.56	-54.01	18.13
Common Equity, 2 Yr. CAGR %	-	26.38	-45.44	-27.27	-33.51
Cash From Operations, 2 Yr. CAGR %	-	49.4	24.26	-14.84	19.83
Capital Expenditures, 2 Yr. CAGR %	-	63.21	-33.95	-1.65	-23.92
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	10.43	9.56	90.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-0.57	-25.41	90.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	35.38	121.33	-66.26
Gross Profit, 3 Yr. CAGR %	-	-	67.44	215.51	-50.77
EBITDA, 3 Yr. CAGR %	-	-	27.61	11.98	2.83
EBITA, 3 Yr. CAGR %	-	-	26.04	11.46	3.03
EBIT, 3 Yr. CAGR %	-	-	26.12	12.83	3.03
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	53.08	15.01	3.72
Net Income, 3 Yr. CAGR %	-	-	52.63	9.71	26.16
Normalized Net Income, 3 Yr. CAGR %	-	-	37.87	12.03	-0.24
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	19.12	7.97	-6.87
Accounts Receivable, 3 Yr. CAGR %	-	-	52.97	27.59	-
Inventory, 3 Yr. CAGR %	-	-	120.88	118.44	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	36.24	27.74	-13.75
Total Assets, 3 Yr. CAGR %	-	-	48.29	2.75	0.89
Tangible Book Value, 3 Yr. CAGR %	-	-	-28.9	-48.06	-42.61
Common Equity, 3 Yr. CAGR %	-	-	-10.6	-29.39	-39.16
Cash From Operations, 3 Yr. CAGR %	-	-	21.39	11.8	4.79
Capital Expenditures, 3 Yr. CAGR %	-	-	8.55	-4.21	-34.74
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	35.85	28.56
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	5.22	19.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-50.73
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-38.83
EBITDA, 5 Yr. CAGR %	-	-	-	-	20.99
EBITA, 5 Yr. CAGR %	-	-	-	-	20.21
EBIT, 5 Yr. CAGR %	-	-	-	-	20.11
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	21.7
Net Income, 5 Yr. CAGR %	-	-	-	-	36.82
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	17.86
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-1.39
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-
Inventory, 5 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-2.02
Total Assets, 5 Yr. CAGR %	-	-	-	-	11.18
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-19.46
Common Equity, 5 Yr. CAGR %	-	-	-	-	-18.5
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	20.76
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-5.83
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-